OxyPrem awarded by Swiss Innovation Agency

20-01-2023 – OxyPrem among the Medtech start-ups enroute to transform the industry

Wysszurich keyvisual oxyprem

After more than three years of milestone-based support and coaching, the Swiss Innovation Agency awarded five medtech start-ups the Innosuisse Certificate, in recognition for their readiness for external investment and sustainable growth. OxyPrem AG, spin-off of our Wyss Zurich project OxyPrem, is among those.

Read more in the article.